SB

Susmita Banerjee

Active Director Director DIN 10599171
DIN 10599171 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Susmita Banerjee

Data last updated:

Susmita Banerjee is a Director at Primita Healthcare Private Limited (since 2024).

DIN 10599171
Primary Designation Director
First Appointment 22 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Primita Healthcare Private Limited U86201KA2024PTC187678
Director22 Apr 20242024Active

Board colleagues of Susmita Banerjee

NameDINCompanyDesignation
Sulekha Kundu10599172Primita Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Primita Healthcare Private Limited
Premium access

Shareholding and investment profile for Susmita Banerjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susmita Banerjee

Susmita Banerjee currently holds 1 directorship: Primita Healthcare Private Limited (Director, since 22 Apr 2024).

Susmita Banerjee was first appointed on 22 Apr 2024 as Director at Primita Healthcare Private Limited.

The current boards of Susmita Banerjee's companies include Sulekha Kundu (Primita Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available